SARS-CoV-2 501Y.V2の変種はより高い感染力を持たないが,免疫脱出能力を持っている
Qianqian Li1, Jianhui Nie1, Jiajing Wu1
1Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC) and WHO Collaborating Center for Standardization and Evaluation of Biologicals, No. 31 Huatuo Street, Daxing District, Beijing 102629, China.
Cell
|March 18, 2021
まとめ
501Y.V2のSARS-CoV-2変種はマウスの細胞では感染性が高まっているが,ヒトの細胞ではそうではない. この変種は中和抗体と回復期血清に耐性があり,ワクチンと治療効果に潜在的に影響する.
科学分野:
- ウイルス学
- 免疫学
- 遺伝学
背景:
- SARS-CoV-2の501Y.V2型は,複数のスパイク変異を伴い,世界的に優勢である.
- 生物学的特徴を理解することは公衆衛生戦略にとって極めて重要です
研究 の 目的:
- SARS-CoV-2変種501Y.V2の感染性と中和感性を調査する.
- 感染性および中和性の観察された変化に起因する変異を特定する.
主な方法:
- 18種類の偽型ウイルスを用いて,様々な細胞の感染性を評価する実験.
- 回復期患者と免疫化されたマウスの単一クローン抗体と血清による中和の評価.
主要な成果:
- 501Y.V2はネズミのACE2過剰発現細胞では感染性が高かったが,他の試験細胞ではそうではなかった.
- 17の中和性モノクローナル抗体のうち12の抗体に対する感受性が著しく低下した.
- 回復期患者と免疫化されたマウスの血清による中和が減少した.
- スパイク受容体結合領域のE484KおよびN501Y変異は,中和抵抗の主要な要因でした.
結論:
- マウス細胞における501Y.V2の感染性の向上は,マウスへの潜在的感染への懸念を高めています.
- 中和抵抗は,既存のモノクローナル抗体とワクチンの有効性が損なわれていることを示唆している.
- この結果は,SARS-CoV-2の変種に対する継続的な監視と対策の必要性を強調しています.
関連する概念動画
Rous Sarcoma Virus (RSV) and Cancer
5.8K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.8K
Single Nucleotide Polymorphisms-SNPs
17.3K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.3K
Viruses with RNA Genomes
350
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
350
Viral Mutations
36.9K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
36.9K
Subviral Agents
281
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
281
Viral Recombination
24.3K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
24.3K


